DOCSLIB.ORG

Supplementary Table S7. (A)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table S7. (A) Supplementary Table S7. (a) (i) Canonical Pathways p-value Genes Mismatch Repair in Eukaryotes 1.349E-07 PCNA, MSH2, RFC4, MSH6, RFC2, SLC19A1, FEN1, RPA1, RFC5, POLD1, EXO1, RFC3 Role of CHK Proteins in Cell Cycle Checkpoint Control 6.310E-06 PPP2R3B, MDC1, RPA1, PLK1, RFC5, CDK1, RAD1, CHEK1, E2F6, PPP2R1A, PCNA, RFC4, CDKN1A, ATMIN, RFC2, SLC19A1, PPP2R2C, BRCA1, E2F2, RFC3, ATM, CDC25A Cell Cycle: G2/M DNA Damage Checkpoint Regulation 2.089E-05 PRKDC, YWHAG, CKS2, CCNB2, PLK1, CDK1, PRKCZ, SKP2, CHEK1, CCNB1, MDM4, TOP2B, CDKN1A, CKS1B, TOP2A, PKMYT1, BRCA1, ATM tRNA Charging 5.495E-05 RARS2, MARS2, GARS, LARS2, DARS2, QARS, MARS, NARS2, EPRS, EARS2, LARS, YARS, AARS2, AARS, VARS, IARS Mitotic Roles of Polo-Like Kinase 5.754E-05 ESPL1, CDC20, ANAPC1/ANAPC1P1, PTTG1, PRC1, CDC7, PPP2R3B, CCNB2, PLK1, CDK1, CCNB1, PPP2R1A, HSP90AB1, PLK2, CAPN1, ANAPC5, PKMYT1, HSP90AA1, FBXO5, PPP2R2C, KIF11, CDC25A Tetrahydrofolate Salvage from 5,10-methenyltetrahydrofolate 7.762E-05 MTHFD2, MTHFD1, MTHFD2L, MTHFD1L, GART Role of BRCA1 in DNA Damage Response 1.047E-04 RBL2, MDC1, RPA1, PLK1, RBL1, RFC5, FANCL, CHEK1, E2F6, FANCB, RFC4, MSH2, CDKN1A, MSH6, RFC2, SLC19A1, BLM, BRCA1, E2F2, RFC3, ATM Germ Cell-Sertoli Cell Junction Signaling 1.413E-04 EPN3, MAP3K11, TUBA3E, PIK3R1, ACTA2, HRAS, MAP3K4, TUBB, TGFBR2, PAK1, WASL, RHOB, TGFB2, PIK3R2, JUP, ACTG2, ATM, PXN, PAK2, NRAS, RHOC, TJP1, RRAS, TUBB4B, MAP3K1, ITGA2, TUBB2A, TUBG1, TUBA4A, RAC1, ITGA3, TUBA1B, RHOQ, TUBA1A, RND3, TGFB3, ZYX, MAP2K3, TUBA3C/TUBA3D, FNBP1, PVRL2 Cell Cycle Control of Chromosomal Replication 2.570E-04 MCM5, MCM3, RPA3, MCM2, CDK4, CDC6, ORC5, CDC7, CDK6, ORC6, RPA1, MCM7 Mechanisms of Viral Exit from Host Cells 4.266E-04 VPS28, SH3GL3, ACTA2, CHMP4B, VPS37C, TSG101, PRKCZ, CHMP6, CHMP2A, VPS36, LMNB2, PRKCH, ACTG2, PDCD6IP, CHMP3 Cell Cycle: G1/S Checkpoint Regulation 7.413E-04 RBL2, PA2G4, HDAC2, SUV39H1, PAK1IP1, SMAD3, CDK6, RBL1, CDKN2B, SKP2, E2F6, CDK4, CDKN1A, TGFB3, TGFB2, CDKN1B, E2F2, ATM, CDC25A GADD45 Signaling 8.710E-04 PCNA, GADD45B, CDK4, CDKN1A, MAP3K4, BRCA1, CDK1, CCNB1, ATM Hereditary Breast Cancer Signaling 9.333E-04 POLR2D, GADD45B, PIK3R1, HRAS, CHEK1, FANCB, XPC, RFC2, SLC19A1, PIK3R2, BLM, BRCA1, ATM, NRAS, HDAC2, RRAS, TUBG1, CDK6, RPA1, RFC5, CDK1, FANCL, CCNB1, MSH2, RFC4, CDK4, CDKN1A, MSH6, POLR2I, RFC3 Epithelial Adherens Junction Signaling 1.230E-03 EPN3, RAPGEF1, MYL6, TUBA3E, ACTA2, MYL5, BMPR2, HRAS, TUBB, TGFBR2, WASL, ARPC4, TGFB2, VCL, JUP, ACTG2, DLL1, NRAS, RRAS, TUBB4B, TUBG1, TUBB2A, ACVR1, RAC1, TUBA4A, TCF7L1, TUBA1B, TUBA1A, WAS, SNAI2, MYH9, SSX2IP, ZYX, LEF1, TUBA3C/TUBA3D, PVRL2 Estrogen-mediated S-phase Entry 1.549E-03 CCNA2, E2F6, CDK4, CDKN1A, CDKN1B, RBL1, CDK1, E2F2, SKP2, CDC25A Cyclins and Cell Cycle Regulation 1.778E-03 PA2G4, HDAC2, SUV39H1, CDK6, PPP2R3B, CCNB2, CDKN2B, CDK1, SKP2, CCNB1, E2F6, CCNA2, PPP2R1A, CDK4, CDKN1A, TGFB3, TGFB2, PPP2R2C, CDKN1B, E2F2, ATM, CDC25A Chronic Myeloid Leukemia Signaling 1.950E-03 PA2G4, BAD, SUV39H1, SMAD3, PIK3R1, HRAS, RBL1, TGFBR2, E2F6, TGFB2, CHUK, PIK3R2, E2F2, ATM, STAT5A, RBL2, NRAS, HDAC2, RRAS, CDK6, BCL2L1, CDK4, CDKN1A, TGFB3, CDKN1B Breast Cancer Regulation by Stathmin1 2.042E-03 CAMK1D, TUBA3E, PIK3R1, PPP1R3C, HRAS, PPP2R3B, GNG13, TUBB, PRKCZ, ROCK2, E2F6, GNB4, PAK1, STMN1, RB1CC1, PLCB1, PPP2R2C, PIK3R2, E2F2, ATM, ADCY9, CALML5, NRAS, RRAS, TUBB4B, TUBB2A, ADCY3, TUBG1, ADCY6, TUBA4A, RAC1, PPP1R11, TSG101, TUBA1B, CDK1, PPP2R1A, TUBA1A, ARHGEF16, ARHGEF6, CDKN1A, PRKCH, TUBA3C/TUBA3D, CDKN1B, CAMK2G Regulation of Cellular Mechanics by Calpain Protease 2.291E-03 CAPN5, PXN, NRAS, RRAS, ITGA2, CDK6, HRAS, ITGA3, CDK1, CCNA2, CAPN1, EZR, CDK4, CAPN9, CAST, VCL, CDKN1B D-glucuronate Degradation I 3.467E-03 AKR1A1, CRYL1, DCXR Protein Ubiquitination Pathway 4.898E-03 UBE2H, HSPA1A/HSPA1B, UBE2V2, DNAJC15, HSPA4, BAG1, UBE2D4, USP10, UCHL5, NEDD4L, PSMC2, BRCA1, PSMB5, DNAJC9, HSPA9, DNAJC25, PSMD3, SKP2, HSPA8, PSMB2, PSMD12, PSMB1, ANAPC5, HSP90AA1, PSMD1, TAP2, USP51, UBE2C, ANAPC1/ANAPC1P1, CDC20, DNAJC12, HSPA6, HSPB8, DNAJC10, DNAJA1, HSP90AB1, PSMD14, DNAJB1, AMFR, HSPA4L, HSPH1, USP30, PSMA1, HSPD1, USP1, DNAJB9, HSPA2, UBE2L6, PSMC1, DNAJC24, USP4, DNAJB11, PSMD2, USP37 Prostate Cancer Signaling 6.607E-03 NRAS, PA2G4, BAD, RRAS, SRD5A1, SUV39H1, NFKBIE, PIK3R1, HRAS, CREB3L4, NFKBIA, CASP9, HSP90AB1, CDKN1A, ATF4, HSP90AA1, LEF1, PIK3R2, CHUK, CDKN1B, ATM Actin Nucleation by ARP-WASP Complex 7.079E-03 NRAS, RHOC, RRAS, ITGA2, RAC1, HRAS, ITGA3, ROCK2, NCK2, WASL, RHOQ, RHOB, RND3, WAS, ARPC4, FNBP1 FAK Signaling 7.586E-03 CAPN5, PXN, NRAS, PAK2, ASAP1, RRAS, PIK3R1, HMMR, ACTA2, ITGA2, RAC1, HRAS, ITGA3, PAK1, WAS, CAPN1, ARHGEF6, CAPN9, PIK3R2, VCL, ACTG2, ATM NRF2-mediated Oxidative Stress Response 8.511E-03 PIK3R1, NQO2, ACTA2, DNAJA4, HSPB8, HRAS, DNAJC10, DNAJC15, DNAJA1, PRKCZ, GSTT1, AKR1A1, GSTM4, DNAJA3, ATF4, GCLM, DNAJB1, PIK3R2, ACTG2, FKBP5, GSTK1, ATM, GSTM1, NRAS, DNAJC9, RRAS, GSTM3, MAP3K1, NQO1, DNAJB9, TXNRD1, FOS, DNAJB11, CCT7, MAP2K3, PRKCH, ABCC4, ENC1, FTH1 Integrin Signaling 8.710E-03 RAPGEF1, MAP3K11, PIK3R1, ACTA2, MYL5, HRAS, NCK2, PAK1, WASL, RHOB, ARF4, GRB7, ARPC4, ACTG2, VCL, PIK3R2, TSPAN4, ATM, CAPN5, PXN, PARVA, TSPAN5, PAK2, NRAS, ASAP1, RRAS, RHOC, ITGA2, RALB, RAC1, BCAR3, ITGA3, MYL12A, RHOQ, RND3, WAS, MYL12B, CAPN1, ZYX, CAPN9, CTTN, FNBP1 Agrin Interactions at Neuromuscular Junction 8.913E-03 GABPB1, PXN, PAK2, NRAS, RRAS, ACTA2, ITGA2, RAC1, HRAS, ERBB3, ITGA3, PAK1, ARHGEF6, LAMB1, DAG1, ACTG2, AGRN, CTTN Aldosterone Signaling in Epithelial Cells 9.550E-03 ICMT, HSPA1A/HSPA1B, SGK1, PIK3R1, DNAJC12, HSPB8, HSPA6, DNAJC10, DNAJC15, DNAJA1, SLC9A1, PRKCZ, HSPA4, HSP90AB1, PLCB1, DNAJB1, PIK3R2, ATM, HSPA4L, DNAJC9, HSPH1, SLC12A2, HSPA9, DNAJC25, HSPD1, DNAJB9, HSPA2, HSPA8, DNAJC24, PIP5K1C, DUSP1, DNAJB11, HSP90AA1, PRKCH (a) (ii) Network Score Molecules in Network Focus Molecules Top Functions 28 ATP6V0E1, BRWD1, C11orf82, C12orf76, CDCA2, CDCA7, CDK4, CENPK, CENPN, CNOT7, DONSON, E2F7, ENDOD1, FAM54A, FAM83D, GPC6, HIST2H2BE 35 Cellular Assembly and Organization, DNA Replication, Recombination, and Repair, Developmental Disorder (includes others), HJURP, HSPD1, KIF20A, KIF2C, MBLAC2, MED30, PDLIM3, PPCS, RNF170, RPS27L, SERF2, SGOL2, SLC29A1, TM7SF2, TMEM219, TMSB15A, TP53INP1, TRIP13 28 CALU, CBX1, CBX6, CCPG1, CREBRF, CRISPLD2, DNMT1, EMC9, ERGIC1, EZH2, FAM46B, GPR68, HIST1H2BJ/HIST1H2BK, HSD17B11, KHSRP, KIFC2, KRT17, 35 Small Molecule Biochemistry, Endocrine System Development and Function, Cellular Development KRT81, LYPD6B, NUDT2, PLK2, RAB35, RALB, RBMS1, RUVBL1, SFR1, SLC25A25, SRD5A1, STX6, SUV39H1, SUZ12, TIPARP, TNS3, TRIM52, VAMP3 25 ACTL6A, AEBP2, Cbp/p300, CDCA3, CDIPT, CENPE, CENPF, CSNK2A2, DNAL4, EED, EIF5B, FJX1, HDAC2, KDM1A, KDM5B, LRCH4, MAPK8IP3, MT1F, NDC80, 34 Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair NEK2, NEK11, NUF2, OGG1, OIP5, PIR, POLD3, PPOX, RNASET2, SAP30, SMARCC1, SMARCE1, SPC25, TOP2A, TOP2B, UBE2C 23 ADARB1, AK4, AMD1, DKK1, DNAJA1, EDN1, EIF1AX, EPHA1, FKBP4, FKBP5, GJA1, GOT1, Hsp90, IP6K2, Jnk, KCNK1, KLF2, LAMB2, MAD2L2, MAP3K11, 33 Drug Metabolism, Endocrine System Development and Function, Lipid Metabolism MSH2, MSH6, NCOA3, PCNA, PGR, PRMT5, RAB9A, S100P, SERPINB8, SLC31A2, SNTB2, TMED10, UCK2, URI1, ZC3H12A 23 26s Proteasome, ADRM1, BRCA1, CDC6, CDCA4, CEP55, CHEK1, CKS1B, DYNLL1, FBXO5, GMNN, HAUS8, KIF11, LMNB2, MCM3, MCM5, MCM7, MCMBP, 33 DNA Replication, Recombination, and Repair, Cell Cycle, Cellular Assembly and Organization NABP1, NEDD1, NFKBIA, ORC5, ORC6, PABPC1, PLK1, PRMT2, PSMA1, PSMB1, PSMB5, RECQL4, SLC39A4, TAF4B, Ubiquitin, UBQLN1, UBQLN2 23 ADD3, AKAP8, AURKA, AURKB, BAZ1A, CDCA8, CHFR, CRIP2, DHRS12, DIO1, DMAP1, ERMAP, H2AFZ, Histone h3, Histone h4, KIF22, KIF4A, LARP1B, NCAPD2, 33 DNA Replication, Recombination, and Repair, Cellular Assembly and Organization, Cell Cycle NCAPD3, NCAPG, PNO1, POLD4, POLE2, POLE3, RPS9, SF3B3, SMC2, SPATS2L, STOM, TACC3, VRK1, WDR1, ZDHHC11, ZNF239 23 20s proteasome, BAG1, CALB2, CD24, CLDN3, CLDN23, COL9A2, DEPDC1, estrogen receptor, F12, FGF13, FXR1, HSPA4, LPXN, LYN, MMP15, N4BP3, NAGK, 33 Neurological Disease, Cell Morphology, Hematological System Development and Function NCAM2, NR2C1, PAAF1, PCDH19, POMP, PPP1R15A, PSMC1, PSMC2, PSMD1, PSMD2, SAT1, TFAP2C, TGFB3, TMEM135, TPP2, TRAFD1, TUFT1 23 APBB3, CA12, DDX39A, DNAJB11, DNAJC10, ELK4, ENO1, GREB1, HCST, HMGB2, HSF1, HSPA8, HSPA1A/HSPA1B, NBPF15 (includes others), NCOA1, NCOA4, 33 Post-Translational Modification, Protein Folding, Drug Metabolism PDZK1, PKMYT1, POLR2D, POLR2I, RAD51AP1, RNA polymerase II, RPA1, SCAF8, SET, SLC27A2, SLC9A8, SLIRP, SMYD3, SPAG7, TBPL1, TFF1, TFIIA, THOC1, THRA 23 ABCC3, ACTA2, APLP2, CCNDBP1, CEP164, Collagen(s), CRTAP, CTPS1, DAG1, DCP1A, DOCK11, GAPVD1, ITGA3, KIF2A, NPR3, PLEC, PLXDC2, PNPLA2, 33 Cancer, Cell-To-Cell Signaling and Interaction, Cell Morphology PODXL, POMGNT1, PTRF, RAB27B, RAI14, SCARA3, SDC1, SDC2, Secretase gamma, SLC35C2, SLC43A2, SVIL, SYVN1, TFAP2A, TRERF1, USP37, YWHAG 22 ACVR1, AHSA1, AIMP2, AKAP1, BAD, BMPR2, CDC42EP5, CHP1, CLIC4, CTGF, DNAJB1, EEF1E1, EPRS, ERK1/2, FAIM3, GPER, GRB7, GRK6, IARS, ID1, IDE, 32 Metabolic Disease, Cellular Development, Cellular Growth and Proliferation LARS, MARS, NEU1, PARVA, Pka, PPAP2C, QARS, RPL8, SLC9A1, SMAD1/5, SRPK1, STAM, SULF2, VEGFB (b) (i) Canonical Pathways p-value Genes Mismatch Repair in Eukaryotes 3.162E-10 MSH3, RFC5, POLD1, PCNA, MSH2, RFC4, MSH6, RFC2, PMS2, SLC19A1, FEN1, EXO1, RFC3
Load more

Recommended publications
  • Deciphering the Functions of Ets2, Pten and P53 in Stromal Fibroblasts in Multiple
    Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Julie Wallace Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Michael C. Ostrowski, PhD, Advisor Gustavo Leone, PhD Denis Guttridge, PhD Dawn Chandler, PhD Copyright by Julie Wallace 2013 Abstract Breast cancer is the second most common cancer in American women, and is also the second leading cause of cancer death in women. It is estimated that nearly a quarter of a million new cases of invasive breast cancer will be diagnosed in women in the United States this year, and approximately 40,000 of these women will die from breast cancer. Although death rates have been on the decline for the past decade, there is still much we need to learn about this disease to improve prevention, detection and treatment strategies. The majority of early studies have focused on the malignant tumor cells themselves, and much has been learned concerning mutations, amplifications and other genetic and epigenetic alterations of these cells. However more recent work has acknowledged the strong influence of tumor stroma on the initiation, progression and recurrence of cancer. Under normal conditions this stroma has been shown to have protective effects against tumorigenesis, however the transformation of tumor cells manipulates this surrounding environment to actually promote malignancy. Fibroblasts in particular make up a significant portion of this stroma, and have been shown to impact various aspects of tumor cell biology.
    [Show full text]
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • Dynamic Control of Enhancer Activity Drives Stage-Specific Gene
    ARTICLE https://doi.org/10.1038/s41467-019-09513-2 OPEN Dynamic control of enhancer activity drives stage-specific gene expression during flower morphogenesis Wenhao Yan 1,7, Dijun Chen 1,2,7, Julia Schumacher 1,2, Diego Durantini2,5, Julia Engelhorn3,6, Ming Chen4, Cristel C. Carles 3 & Kerstin Kaufmann 1 fi 1234567890():,; Enhancers are critical for developmental stage-speci c gene expression, but their dynamic regulation in plants remains poorly understood. Here we compare genome-wide localization of H3K27ac, chromatin accessibility and transcriptomic changes during flower development in Arabidopsis. H3K27ac prevalently marks promoter-proximal regions, suggesting that H3K27ac is not a hallmark for enhancers in Arabidopsis. We provide computational and experimental evidence to confirm that distal DNase І hypersensitive sites are predictive of enhancers. The predicted enhancers are highly stage-specific across flower development, significantly associated with SNPs for flowering-related phenotypes, and conserved across crucifer species. Through the integration of genome-wide transcription factor (TF) binding datasets, we find that floral master regulators and stage-specific TFs are largely enriched at developmentally dynamic enhancers. Finally, we show that enhancer clusters and intronic enhancers significantly associate with stage-specific gene regulation by floral master TFs. Our study provides insights into the functional flexibility of enhancers during plant devel- opment, as well as hints to annotate plant enhancers. 1 Department for Plant Cell and Molecular Biology, Institute for Biology, Humboldt-Universität zu Berlin, 10115 Berlin, Germany. 2 Institute for Biochemistry and Biology, University of Potsdam, 14476 Potsdam, Germany. 3 Université Grenoble Alpes (UGA), CNRS, CEA, INRA, IRIG-LPCV, 38000 Grenoble, France, 38000 Grenoble, France.
    [Show full text]
  • An in Vivo Screen Identifies PYGO2 As a Driver for Metastatic Prostate Cancer
    Published OnlineFirst May 16, 2018; DOI: 10.1158/0008-5472.CAN-17-3564 Cancer Molecular Cell Biology Research An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer Xin Lu1,2,3, Xiaolu Pan1, Chang-Jiun Wu4, Di Zhao1, Shan Feng2, Yong Zang5, Rumi Lee1, Sunada Khadka1, Samirkumar B. Amin4, Eun-Jung Jin6, Xiaoying Shang1, Pingna Deng1,Yanting Luo2,William R. Morgenlander2, Jacqueline Weinrich2, Xuemin Lu2, Shan Jiang7, Qing Chang7, Nora M. Navone8, Patricia Troncoso9, Ronald A. DePinho1, and Y. Alan Wang1 Abstract Advanced prostate cancer displays conspicuous chromosomal inhibits prostate cancer cell invasion in vitro and progression of instability and rampant copy number aberrations, yet the identity primary tumor and metastasis in vivo. In clinical samples, PYGO2 of functional drivers resident in many amplicons remain elusive. upregulation associated with higher Gleason score and metastasis Here, we implemented a functional genomics approach to identify to lymph nodes and bone. Silencing PYGO2 expression in patient- new oncogenes involved in prostate cancer progression. Through derived xenograft models impairs tumor progression. Finally, integrated analyses of focal amplicons in large prostate cancer PYGO2 is necessary to enhance the transcriptional activation in genomic and transcriptomic datasets as well as genes upregulated response to ligand-induced Wnt/b-catenin signaling. Together, our in metastasis, 276 putative oncogenes were enlisted into an in vivo results indicate that PYGO2 functions as a driver oncogene in the gain-of-function tumorigenesis screen. Among the top positive 1q21.3 amplicon and may serve as a potential prognostic bio- hits, we conducted an in-depth functional analysis on Pygopus marker and therapeutic target for metastatic prostate cancer.
    [Show full text]
  • Genes Retina/RPE Choroid Sclera
    Supplementary Materials: Genes Retina/RPE Choroid Sclera Fold Change p-value Fold Change p-value Fold Change p-value PPFIA2 NS NS 2.35 1.3X10-3 1.5 1.6X10-3 PTPRF 1.24 2.65X10-5 6.42 7X10-4 1.11 1X10-4 1.19 2.65X10-5 NS NS 1.11 3.3X10-3 PTPRR 1.44 2.65X10-5 3.04 4.7X10-3 NS NS Supplementary Table S1. Genes Differentially Expressed Related to Candidate Genes from Association. Genes selected for follow up validation by real time quantitative PCR. Multiple values for each gene indicate multiple probes within the same gene. NS indicates the fold change was not statistically significant. Gene/SNP Assay ID rs4764971 C__30866249_10 rs7134216 C__30023434_10 rs17306116 C__33218892_10 rs3803036 C__25749934_20 rs824311 C___8342112_10 PPFIA2 Hs00170308_m1 PTPRF Hs00160858_m1 PTPRR Hs00373136_m1 18S Hs03003631_g1 GAPDH Hs02758991_g1 Supplementary Table S2. Taqman® Genotyping and Gene Expression Assay Identification Numbers. SNP Chimp Orangutan Rhesus Marmoset Mouse Rat Cow Pig Guinea Pig Dog Elephant Opossum Chicken rs3803036 X X X X X X X X X X X X X rs1520562 X X X X X X rs1358228 X X X X X X X X X X X rs17306116 X X X X X X rs790436 X X X X X X X rs1558726 X X X X X X X X rs741525 X X X X X X X X rs7134216 X X X X X X rs4764971 X X X X X X X Supplementary Table S3. Conservation of Top SNPs from Association. X indicates SNP is conserved.
    [Show full text]
  • Funkce CDK12 a CDK13 V Regulaci Transkripce Hana Paculová
    MASARYKOVA UNIVERZITA PŘÍRODOVĚDECKÁ FAKULTA ÚSTAV BIOCHEMIE Funkce CDK12 a CDK13 v regulaci transkripce Disertační práce Hana Paculová Školitel: Mgr. Jiří Kohoutek, Ph.D Brno 2018 Bibliogra cký záznam Autorka: Mgr. Hana Paculová Prrodovedecáá aaául,a鏈 Maaarkáova unvverv,a Úa,av bvochemve Název práce: Funáce CDK12 a CDK13 v regulacv ,ranaárvpce Studijní program: Bvochemve Studijní obor: Bvochemve Školitel: Mgr. Jvr Kohou,eá鏈 Ph.D Akademický rok: 2017/2018 Po et stran: 89 Klí ová slova: Ckálvn-dependen,n ávnaaa鏈 CDK12鏈 ,ranaárvpce鏈 RNA polkmeraaa II鏈 raáovvna vaječnáů鏈 CHK1 Bibliographic entry Author: Mgr. Hana Paculová Facul,k oa acvence鏈 Maaarká unvverav,k Department of Biochemistry Title oF dissertation: CDK12 and CDK13 aunc,von vn ,ranacrvp,von regula,von Degree programme: Bvochemva,rk Field oF study: Bvochemva,rk Supervisor: Mgr. Jvr Kohou,eá鏈 Ph.D Academic year: 2017/2018 Number oF pages: 89 Keywords: Ckclvn-dependen ávnaae鏈 CDK12鏈 ,ranacrvp,von鏈 RNA polkmeraae II鏈 ovarvan cancer鏈 CHK1 Abstrakt Ckálvn-dependen,n ávnaaa 12 (CDK12) je ,ranaárvpčn ávnaaa鏈 á,erá rd expreav avých clových genů ,m鏈 že aoaaorkluje RNA polkmeraau II v průbehu elongačn aáe ,ranaárvpce. CDK12 je apojena do neáolváa bunečných preceaů鏈 což ahrnuje odpoveď na pošáoen DNA鏈 vývoj a bunečnou dvaerencvacv a aea,rvh mRNA. CDK12 bkla popaána jaáo jeden genů鏈 á,eré jaou čaa,o mu,ovánk v hvgh-grade aerónm ovarválnm áarcvnomu鏈 nvcméne vlvv ,ech,o mu,ac na aunácv CDK12 a jejvch role v áarcvnogenev dopoaud nebkla a,anovena. Zjva,vlv jame鏈 že ve,švna mu,ac CDK12鏈 á,eré bklk naleenk v nádorech鏈 brán vk,voren áomplexu CDK12 a Ckálvnem K a vnhvbuj ávnaaovou aá,vvv,u CDK12.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Datasheet Blank Template
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . MTMR3 (N-20): sc-47187 BACKGROUND RECOMMENDED SECONDARY REAGENTS Myotubularin and the myotubularin-related proteins (MTMR1-9) belong to a To ensure optimal results, the following support (secondary) reagents are highly conserved family of eukaryotic phosphatases. They are protein tyrosine recommended: 1) Western Blotting: use donkey anti-goat IgG-HRP: sc-2020 phosphatases that utilize inositol phospholipids, rather than phosphoproteins, (dilution range: 1:2000-1:100,000) or Cruz Marker™ compatible donkey as substrates. MTMR family members hydrolyze both Phosphatidylinositol anti- goat IgG-HRP: sc-2033 (dilution range: 1:2000-1:5000), Cruz Marker™ 3-phosphate (PtdIns3P) and PtdIns P2. MTMR2 interacts with MTMR5, an Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent: inactive family member that increases the enzymatic activity of MTMR2 and sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecip- dictates its subcellular localization. Mutations in MTMR2 cause autosomal itation: use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml). recessive Charcot-Marie-Tooth type 4B1 (CMT4B1), which is characterized 3) Immunofluorescence: use donkey anti-goat IgG-FITC: sc-2024 (dilution by reduced nerve conduction velocities, focally folded myelin sheaths and range: 1:100-1:400) or donkey anti-goat IgG-TR: sc-2783 (dilution range: demyelination. MTMR3 and MTMR4 can either interact with each other or self 1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. associate. MTMR6 regulates the activity of the calcium-activated potassium channel 3.1. MTMR9 regulates the activity of MTMR7 and MTMR8.
    [Show full text]
  • GIGANTUS1 (GTS1), a Member of Transducin/WD40 Protein
    Gachomo et al. BMC Plant Biology 2014, 14:37 http://www.biomedcentral.com/1471-2229/14/37 RESEARCH ARTICLE Open Access GIGANTUS1 (GTS1), a member of Transducin/WD40 protein superfamily, controls seed germination, growth and biomass accumulation through ribosome-biogenesis protein interactions in Arabidopsis thaliana Emma W Gachomo1,2†, Jose C Jimenez-Lopez3,4†, Lyla Jno Baptiste1 and Simeon O Kotchoni1,2* Abstract Background: WD40 domains have been found in a plethora of eukaryotic proteins, acting as scaffolding molecules assisting proper activity of other proteins, and are involved in multi-cellular processes. They comprise several stretches of 44-60 amino acid residues often terminating with a WD di-peptide. They act as a site of protein-protein interactions or multi-interacting platforms, driving the assembly of protein complexes or as mediators of transient interplay among other proteins. In Arabidopsis, members of WD40 protein superfamily are known as key regulators of plant-specific events, biologically playing important roles in development and also during stress signaling. Results: Using reverse genetic and protein modeling approaches, we characterize GIGANTUS1 (GTS1), a new member of WD40 repeat protein in Arabidopsis thaliana and provide evidence of its role in controlling plant growth development. GTS1 is highly expressed during embryo development and negatively regulates seed germination, biomass yield and growth improvement in plants. Structural modeling analysis suggests that GTS1 folds into a β-propeller with seven pseudo symmetrically arranged blades around a central axis. Molecular docking analysis shows that GTS1 physically interacts with two ribosomal protein partners, a component of ribosome Nop16, and a ribosome-biogenesis factor L19e through β-propeller blade 4 to regulate cell growth development.
    [Show full text]
  • Hras Intracellular Trafficking and Signal Transduction Jodi Ho-Jung Mckay Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2007 HRas intracellular trafficking and signal transduction Jodi Ho-Jung McKay Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Cancer Biology Commons, Cell Biology Commons, Genetics and Genomics Commons, and the Medical Cell Biology Commons Recommended Citation McKay, Jodi Ho-Jung, "HRas intracellular trafficking and signal transduction" (2007). Retrospective Theses and Dissertations. 13946. https://lib.dr.iastate.edu/rtd/13946 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. HRas intracellular trafficking and signal transduction by Jodi Ho-Jung McKay A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Genetics Program of Study Committee: Janice E. Buss, Co-major Professor Linda Ambrosio, Co-major Professor Diane Bassham Drena Dobbs Ted Huiatt Iowa State University Ames, Iowa 2007 Copyright © Jodi Ho-Jung McKay, 2007. All rights reserved. UMI Number: 3274881 Copyright 2007 by McKay, Jodi Ho-Jung All rights reserved. UMI Microform 3274881 Copyright 2008 by ProQuest Information and Learning Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. ProQuest Information and Learning Company 300 North Zeeb Road P.O.
    [Show full text]